Two medicines, side by side
Albuterol vs prednisone
Albuterol and prednisone are both labeled for asthma. Drugs@FDA records approvals of albuterol since 1981 and of prednisone since 1955. Pharmacies paid $0.288 per albuterol sulfate 2 mg tablet and $0.0643 per prednisone 20 mg tablet (NADAC, October 7, 2026); the strengths differ, so the two prices are not like for like. In FDA's classes, albuterol is a beta2-adrenergic agonist and prednisone a corticosteroid.
Check it at the source: the albuterol FDA label on DailyMed (effective April 30, 2026); the prednisone FDA label on DailyMed (effective April 22, 2025).
Highlights of the albuterol record
Albuterol (Ventolin) · label of April 30, 2026
Used for
From the label: indicationsAlbuterol Inhalation Solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease).
On the market
- Earliest approval on file
- May 1, 1981
- Generic labelers
- 40 labelers
- Pharmacy cost
- $0.288 per tablet
Supply and safety
- Shortage
- Resolved
- Recalls
- 20
Highlights of the prednisone record
Prednisone (Meticorten) · label of April 22, 2025
Used for
From the label: indicationsPrednisone tablets and solutions are indicated in the following conditions: 1. […]
On the market
- Earliest approval on file
- February 21, 1955
- Generic labelers
- 45 labelers
- Pharmacy cost
- $0.0643 per tablet
Supply and safety
- Shortage
- No current entry
- Recalls
- 10
Source: FDA drug labels via openFDA (Albuterol label of April 30, 2026, Prednisone label of April 22, 2025); NDC Directory, Drugs@FDA, NADAC, FDA shortages and recalls (October 8, 2026)
How do albuterol and prednisone differ on the record?
In FDA's classes, albuterol is a beta2-adrenergic agonist and prednisone a corticosteroid.
Generics: albuterol since 1989; prednisone since 1971 (Drugs@FDA).
| Albuterol | Prednisone | |
|---|---|---|
| Labeled for | Asthma | Osteoarthritis, Asthma, Allergies, Herpes and shingles, Leukemia, lymphoma and myeloma, Crohn's disease and ulcerative colitis, Multiple sclerosis, Eczema (atopic dermatitis), Anemia, Organ transplant rejection |
| Pharmacologic class | beta2-Adrenergic Agonist | Corticosteroid |
| How it works (label) | n/a | n/a |
| Half-life (label) | n/a | n/a |
| Earliest approval on file (Drugs@FDA) | May 1, 1981 | February 21, 1955 |
| First generic approved | January 30, 1989 | December 23, 1971 |
| Generic labelers (NDC) | 40 labelers | 45 labelers |
| Pharmacy cost (NADAC, each one's most listed form; strengths differ) | $0.288 per tablet (Albuterol sulfate 2 mg tablet) | $0.0643 per tablet (Prednisone 20 mg tablet) |
| 12-month price change | -38% | -15% |
| Boxed warning | No | No |
| Shortage now | Resolved | No current entry |
| Recalls recorded | 20 | 10 |
| FAERS reports (a report is not proof of cause; counts follow how widely a medicine is used) | 292,136 | 499,950 |
| DEA schedule | none | none |
Source: Drugs@FDA, FDA NDC Directory, CMS NADAC of October 7, 2026, FDA shortages and recalls, FAERS via openFDA (FDA files October 8, 2026)
What next?
- Alternatives to albuterol
- every medicine labeled for the same conditions